Residual Inflammatory Potential in Patients with Treated Non-Definite and Definite Familial Hypercholesterolaemia: A Clinical Study
Journal of Personalized Medicine · 14.08.2026 · 16 (8) · 429
DOI: 10.3390/jpm16080429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 14.08.2026. Verfasst von Patrycja Brzóska-Ritter und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, School of Health Sciences, Medical University of Silesia, 40-635 Katowice, Poland. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia.
Abstract (Originalsprache)
Background
Familial hypercholesterolemia (FH) is associated with accelerated atherosclerosis and an increased risk of cardiovascular disease.
Aims
To evaluate circulating biomarkers of inflammation and atherosclerosis in patients with clinically suspected FH stratified according to the Dutch Lipid Clinic Network (DLCN) criteria.
Methods
This cross-sectional study included 80 patients (mean age, 53.4 [13.2] years; 58% women) receiving maximally tolerated lipid-lowering therapy (statins ± ezetimibe). Serum concentrations of lipoprotein-associated phospholipase A2 (Lp-PLA2), tumor necrosis factor-α (TNF-α), apolipoprotein B (ApoB), oxidized low-density lipoprotein (oxLDL), and monocyte chemoattractant protein-1 (MCP-1) were measured. Participants were classified as definite FH (DLCN score > 8; n = 45) or non-definite FH (DLCN score ≤ 8; n = 35). Biomarker concentrations were analyzed according to the above subgroups and sex.
Results
Patients with definite FH had significantly higher serum Lp-PLA2 concentrations (62.2 [33.8] vs. 46.5 [19.9] ng/mL; p = 0.03) and TNF-α concentrations (6.94 [4.53] vs. 4.51 [2.93] pg/mL; p = 0.02) compared to non-definite FH, whereas ApoB, oxLDL, and MCP-1 concentrations did not differ significantly between the subgroups. Women had significantly higher TNF-α concentrations compared to men (6.57 [4.74] vs. 4.60 [2.20] pg/mL; p = 0.04) with no differences among other cytokines.
Conclusions
Patients with definite FH exhibited persistently higher circulating Lp-PLA2 and TNF-α concentrations despite maximally tolerated lipid-lowering therapy, suggesting ongoing activation of specific inflammatory pathways. These findings support further investigation of Lp-PLA2 and TNF-α as candidate biomarkers for cardiovascular risk assessment in FH.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, School of Health Sciences, Medical University of Silesia, 40-635 Katowice, Poland.
ORCID-Profile: Patrycja Brzóska-Ritter, Piotr Żarczyński, Maciej Haberka
Förderung
- Medical University of Silesia
Zitieren
APA
Brzóska-Ritter, P., Żarczyński, P., & Haberka, M. (2026). Residual Inflammatory Potential in Patients with Treated Non-Definite and Definite Familial Hypercholesterolaemia: A Clinical Study. Journal of Personalized Medicine, 16(8), 429. https://doi.org/10.3390/jpm16080429
Vancouver
Brzóska-Ritter P, Żarczyński P, Haberka M. Residual Inflammatory Potential in Patients with Treated Non-Definite and Definite Familial Hypercholesterolaemia: A Clinical Study. Journal of Personalized Medicine. 2026;16(8):429. doi:10.3390/jpm16080429
BibTeX
@article{BrzskaRitter2026,
author = {Brzóska-Ritter, Patrycja and Żarczyński, Piotr and Haberka, Maciej},
title = {Residual Inflammatory Potential in Patients with Treated Non-Definite and Definite Familial Hypercholesterolaemia: A Clinical Study},
journal = {Journal of Personalized Medicine},
year = {2026},
volume = {16},
number = {8},
pages = {429},
doi = {10.3390/jpm16080429}
}
EUVIMED